Published in J Virol on October 01, 1985
Lysine residue 121 in the proposed ATP-binding site of the v-mos protein is required for transformation. Proc Natl Acad Sci U S A (1985) 1.74
Expression of c-mos RNA in germ cells of male and female mice. Proc Natl Acad Sci U S A (1987) 1.68
Characterization of the TPR-MET oncogene p65 and the MET protooncogene p140 protein-tyrosine kinases. Proc Natl Acad Sci U S A (1988) 1.64
DNA-binding activity of papillomavirus proteins. J Virol (1987) 1.54
Microinjection of antisense c-mos oligonucleotides prevents meiosis II in the maturing mouse egg. Proc Natl Acad Sci U S A (1989) 1.48
Mouse Mos protooncogene product is present and functions during oogenesis. Proc Natl Acad Sci U S A (1989) 1.30
Identification of the human papillomavirus type 6b L1 open reading frame protein in condylomas and corresponding antibodies in human sera. J Virol (1987) 1.26
Chicken homolog of the mos proto-oncogene. Mol Cell Biol (1988) 1.21
Localization of the v-rel protein in reticuloendotheliosis virus strain T-transformed lymphoid cells. J Virol (1986) 1.16
A new recombinant DNA strategy for the molecular cloning of rare membrane proteins. Biochem J (1990) 1.11
mos gene transforming efficiencies correlate with oocyte maturation and cytostatic factor activities. Mol Cell Biol (1991) 0.97
Identification of the human papillomavirus E2 protein in genital tract tissues. J Virol (1988) 0.95
Dose-dependent regulation of macrophage differentiation by mos mRNA in a human monocytic cell line. EMBO J (1989) 0.86
A temperature-sensitive mutant of the myeloproliferative sarcoma virus, altered by a point mutation in the mos oncogene, has been modified as a selectable retroviral vector. J Virol (1987) 0.85
Nucleoside triphosphate-dependent DNA-binding properties of mos protein. Proc Natl Acad Sci U S A (1987) 0.85
Mos in the oocyte: how to use MAPK independently of growth factors and transcription to control meiotic divisions. J Signal Transduct (2010) 0.85
Transforming mutant v-mos protein kinases that are deficient in in vitro autophosphorylation. Mol Cell Biol (1989) 0.82
v-mos protein produced by in vitro translation has protein kinase activity. J Virol (1990) 0.82
Inhibition of v-Mos kinase activity by protein kinase A. Mol Cell Biol (1996) 0.81
A comparative endpoint study of lesions induced by MoMuSV-m1, MoMuSV-HT1, MoMuSV-124 and MoMuSV-349. Int J Exp Pathol (1993) 0.79
v-mos proteins encoded by myeloproliferative sarcoma virus and its ts159 mutant. J Virol (1992) 0.76
Increased amount of a 25-kilodalton phosphoprotein after v-mos transfection of CHO cells. Mol Cell Biol (1988) 0.75
New M13 vectors for cloning. Methods Enzymol (1983) 90.74
Cloning in single-stranded bacteriophage as an aid to rapid DNA sequencing. J Mol Biol (1980) 61.16
Viral src gene products are related to the catalytic chain of mammalian cAMP-dependent protein kinase. Proc Natl Acad Sci U S A (1982) 7.22
Comparative biochemical properties of normal and activated human ras p21 protein. Nature (1984) 6.50
Nucleotide sequence of the genome of a murine sarcoma virus. Cell (1981) 5.48
Rescue of the defective genome of Moloney sarcoma virus from a noninfectious hamster tumor and the production of pseudotype sarcoma viruses with various murine leukemia viruses. Proc Natl Acad Sci U S A (1966) 5.34
Properties of a normal mouse cell DNA sequence (sarc) homologous to the src sequence of Moloney sarcoma virus. Science (1980) 5.30
The product of ras is a GTPase and the T24 oncogenic mutant is deficient in this activity. Nature (1984) 4.61
Activation of the transforming potential of a normal cell sequence: a molecular model for oncogenesis. Science (1981) 4.27
Nucleotide sequence and formation of the transforming gene of a mouse sarcoma virus. Nature (1981) 4.05
Nonproducer clones of murine sarcoma virus transformed BALB-3T3 cells. Virology (1970) 3.85
Human DNA sequence homologous to the transforming gene (mos) of Moloney murine sarcoma virus. Proc Natl Acad Sci U S A (1982) 3.14
A heteroduplex study of the sequence relationships between the RNAs of M-MSV and M-MLV. Cell (1977) 2.96
Nucleotide sequence analysis of the transforming region and large terminal redundancies of Moloney murine sarcoma virus. Proc Natl Acad Sci U S A (1980) 2.93
Nucleotide sequences in mouse DNA and RNA specific for Moloney sarcoma virus. Proc Natl Acad Sci U S A (1976) 2.86
Ha-ras proteins exhibit GTPase activity: point mutations that activate Ha-ras gene products result in decreased GTPase activity. Proc Natl Acad Sci U S A (1985) 2.58
Complete nucleotide sequence and organization of the Moloney murine sarcoma virus genome. Science (1981) 2.51
Rous sarcoma virus transforming protein, p60src, expressed in E. coli, functions as a protein kinase. Nature (1981) 2.37
Detection of a transforming gene product in cells transformed by Moloney murine sarcoma virus. Cell (1982) 2.27
Activation of the c-mos oncogene in a mouse plasmacytoma by insertion of an endogenous intracisternal A-particle genome. Proc Natl Acad Sci U S A (1983) 2.23
The transforming protein of Moloney murine sarcoma virus is a soluble cytoplasmic protein. Cell (1983) 2.02
The transforming gene of Moloney murine sarcoma virus. Nature (1979) 1.98
P85gag-mos encoded by ts110 Moloney murine sarcoma virus has an associated protein kinase activity. Proc Natl Acad Sci U S A (1983) 1.95
Expression of normal and transforming H-ras genes in Escherichia coli and purification of their encoded p21 proteins. Proc Natl Acad Sci U S A (1984) 1.94
Affinity labeling of the protein kinase associated with the epidermal growth factor receptor in membrane vesicles from A431 cells. J Biol Chem (1982) 1.89
Expression of c-mos proto-oncogene transcripts in mouse tissues. Nature (1985) 1.78
Localization of tyrosine kinase-coding region in v-abl oncogene by the expression of v-abl-encoded proteins in bacteria. J Biol Chem (1985) 1.70
Serine kinase activity associated with Maloney murine sarcoma virus-124-encoded p37mos. Virology (1985) 1.67
Rearrangement of the oncogene c-mos in mouse myeloma NSI and hybridomas. Nature (1984) 1.66
Analysis of transforming gene products from Moloney murine sarcoma virus. Cell (1981) 1.51
Rearranged c-mos locus in a MOPC 21 murine myeloma cell line and its persistence in hybridomas. Nature (1984) 1.38
Modelling the ATP-binding site of oncogene products, the epidermal growth factor receptor and related proteins. FEBS Lett (1984) 1.33
Mouse c-mos oncogene activation is prevented by upstream sequences. Proc Natl Acad Sci U S A (1984) 1.30
High-level expression in Escherichia coli of the carboxy-terminal sequences of the avian myelocytomatosis virus (MC29) v-myc protein. Gene (1983) 1.28
An MSV-specific subgenomic mRNA in MSV-transformed G8-124 cells. Cell (1979) 1.28
Tyrosine protein kinases. Adv Cyclic Nucleotide Protein Phosphorylation Res (1984) 1.23
The membrane glycoprotein encoded by the retroviral oncogene v-erb-B is structurally related to tyrosine-specific protein kinases. Proc Natl Acad Sci U S A (1984) 1.23
Affinity labeling of the nucleotide binding site of the catalytic subunit of cAMP-dependent protein kinase using p-fluorosulfonyl-[14C]benzoyl 5'-adenosine. Identification of a modified lysine residue. J Biol Chem (1979) 1.15
Identification of the catalytic subunit of casein kinase II by affinity labeling with 5'-p-fluorosulfonylbenzoyl adenosine. J Biol Chem (1981) 1.06
The "sarcoma-specific" region of Moloney murine sarcoma virus 124. Proc Natl Acad Sci U S A (1978) 1.04
Recombinational junctions of variants of Moloney murine sarcoma virus: generation and divergence of a mammalian transforming gene. J Virol (1983) 1.03
Expression of transforming region of Moloney murine sarcoma virus in Escherichia coli as a fusion protein with small tumor antigen of polyoma virus. Proc Natl Acad Sci U S A (1982) 0.86
Affinity labeling of the inhibitory DPNH site of bovine liver glutamate dehydrogenase by 5'-fluorosulfonylbenzoyl adenosine. J Biol Chem (1975) 0.84
Nucleotide sequence of the transforming gene of m1 murine sarcoma virus. J Virol (1984) 0.81
Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science (1998) 10.53
Transformation of mammalian cells by constitutively active MAP kinase kinase. Science (1994) 8.69
Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science (1991) 8.68
Nucleotide sequences of integrated Moloney sarcoma provirus long terminal repeats and their host and viral junctions. Proc Natl Acad Sci U S A (1980) 7.77
cPLA2 is phosphorylated and activated by MAP kinase. Cell (1993) 6.61
Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature (1984) 5.85
Properties of a normal mouse cell DNA sequence (sarc) homologous to the src sequence of Moloney sarcoma virus. Science (1980) 5.30
Construction and characterization of a recombinant plasmid encoding the gene for the thymidine kinase of Herpes simplex type 1 virus. Gene (1979) 5.09
Abnormal centrosome amplification in the absence of p53. Science (1996) 4.60
Function of c-mos proto-oncogene product in meiotic maturation in Xenopus oocytes. Nature (1988) 4.24
Mechanism of met oncogene activation. Cell (1986) 4.20
The c-mos proto-oncogene product is a cytostatic factor responsible for meiotic arrest in vertebrate eggs. Nature (1989) 4.13
Construction of a general human chromosome jumping library, with application to cystic fibrosis. Science (1987) 3.87
Inactivation of LRG-47 and IRG-47 reveals a family of interferon gamma-inducible genes with essential, pathogen-specific roles in resistance to infection. J Exp Med (2001) 3.64
Cloning of herpes simplex type 1 DNA fragments in a bacteriophage lambda vector. Science (1979) 3.47
The human met oncogene is related to the tyrosine kinase oncogenes. Nature (1985) 3.46
Biological activity of cloned Moloney sarcoma virus DNA: Terminally redundant sequences may enhance transformation efficiency. Proc Natl Acad Sci U S A (1980) 3.29
Use of trimethoprim to prevent overgrowth by Proteus in the cultivation of N. gonorrhoeae. Br J Vener Dis (1970) 3.24
Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner. Proc Natl Acad Sci U S A (1997) 3.19
Structures of two spliced herpes simplex virus type 1 immediate-early mRNA's which map at the junctions of the unique and reiterated regions of the virus DNA S component. J Virol (1981) 3.19
Human DNA sequence homologous to the transforming gene (mos) of Moloney murine sarcoma virus. Proc Natl Acad Sci U S A (1982) 3.14
Genomic instability and apoptosis are frequent in p53 deficient young mice. Oncogene (1997) 3.01
Cloning of integrated Moloney sarcoma proviral DNA sequences in bacteriophage lambda. Proc Natl Acad Sci U S A (1979) 2.98
Activating mutations for the met tyrosine kinase receptor in human cancer. Proc Natl Acad Sci U S A (1997) 2.92
Mos stimulates MAP kinase in Xenopus oocytes and activates a MAP kinase kinase in vitro. Mol Cell Biol (1993) 2.87
Pathogen-specific loss of host resistance in mice lacking the IFN-gamma-inducible gene IGTP. Proc Natl Acad Sci U S A (2000) 2.80
Serum-induced translocation of mitogen-activated protein kinase to the cell surface ruffling membrane and the nucleus. J Cell Biol (1993) 2.74
Expression of the TMPRSS2:ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancer. Br J Cancer (2007) 2.62
The product of the mos proto-oncogene as a candidate "initiator" for oocyte maturation. Science (1989) 2.58
Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor. Mol Cell Biol (1992) 2.53
Met receptor tyrosine kinase: enhanced signaling through adapter proteins. Oncogene (2000) 2.52
DNA sequence of an immediate-early gene (IEmRNA-5) of herpes simplex virus type I. Nucleic Acids Res (1982) 2.50
Specific proteolysis of the c-mos proto-oncogene product by calpain on fertilization of Xenopus eggs. Nature (1989) 2.47
Degradation of the Met tyrosine kinase receptor by the ubiquitin-proteasome pathway. Mol Cell Biol (1997) 2.43
Structure of varicella-zoster virus DNA. J Virol (1981) 2.43
Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation. Proc Natl Acad Sci U S A (1994) 2.36
c-mos proto-oncogene RNA transcripts in mouse tissues: structural features, developmental regulation, and localization in specific cell types. Mol Cell Biol (1987) 2.35
A novel germ line juxtamembrane Met mutation in human gastric cancer. Oncogene (2000) 2.35
Met and hepatocyte growth factor/scatter factor expression in human gliomas. Cancer Res (1997) 2.30
Facial expression megamix: tests of dimensional and category accounts of emotion recognition. Cognition (1997) 2.10
Severely encrusted polyurethane ureteral stents: management and analysis of potential risk factors. Urology (2001) 2.10
The met proto-oncogene receptor and lumen formation. Science (1992) 2.08
Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis network. Mol Cell Biol (1996) 2.05
Recent Advances in Alcoholic Liver Disease I. Role of intestinal permeability and endotoxemia in alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol (2004) 2.04
Meiotic initiation by the mos protein in Xenopus. Nature (1992) 2.00
Wasp recruitment to the T cell:APC contact site occurs independently of Cdc42 activation. Immunity (2001) 1.93
New method for detecting cellular transforming genes. Science (1982) 1.92
Hepatocyte growth factor/scatter factor-Met signaling in tumorigenicity and invasion/metastasis. J Mol Med (Berl) (1996) 1.91
Sodium dodecylsulfate-dependent anomalies in gel electrophoresis: alterations in the banding patterns of foot-and-mouth disease virus polypeptides. Anal Biochem (1974) 1.81
Expression of c-mos proto-oncogene transcripts in mouse tissues. Nature (1985) 1.78
The Met proto-oncogene mesenchymal to epithelial cell conversion. Science (1994) 1.77
The mutationally activated Met receptor mediates motility and metastasis. Proc Natl Acad Sci U S A (1998) 1.76
The inducibly expressed GTPase localizes to the endoplasmic reticulum, independently of GTP binding. J Biol Chem (1997) 1.75
Cutaneous metastases in renal cell carcinoma. Urol Int (1999) 1.74
Identification of a novel GTPase, the inducibly expressed GTPase, that accumulates in response to interferon gamma. J Biol Chem (1996) 1.66
Isoforms of the human ets-1 protein: generation by alternative splicing and differential phosphorylation. Oncogene (1990) 1.65
Mechanical force regulation of myofibroblast differentiation in cardiac fibroblasts. Am J Physiol Heart Circ Physiol (2003) 1.65
Transactivation of gene expression by Myc is inhibited by mutation at the phosphorylation sites Thr-58 and Ser-62. Proc Natl Acad Sci U S A (1993) 1.65
Characterization of the TPR-MET oncogene p65 and the MET protooncogene p140 protein-tyrosine kinases. Proc Natl Acad Sci U S A (1988) 1.64
Three additional DNA polymorphisms in the met gene and D7S8 locus: use in prenatal diagnosis of cystic fibrosis. J Pediatr (1987) 1.63
Signaling pathways in Ras-mediated tumorigenicity and metastasis. Proc Natl Acad Sci U S A (1998) 1.63
The von Hippel-Lindau tumor suppressor gene inhibits hepatocyte growth factor/scatter factor-induced invasion and branching morphogenesis in renal carcinoma cells. Mol Cell Biol (1999) 1.62
Evidence that MIG-6 is a tumor-suppressor gene. Oncogene (2006) 1.62
Structure, tissue-specific expression, and transforming activity of the mouse met protooncogene. Cell Growth Differ (1990) 1.62
The ras oncogene-mediated sensitization of human cells to topoisomerase II inhibitor-induced apoptosis. J Natl Cancer Inst (1999) 1.61
Molecular cloning and physical mapping of varicella-zoster virus DNA. Proc Natl Acad Sci U S A (1982) 1.60
Laparoscopic versus open radical nephrectomy for large renal tumors: a long-term prospective comparison. J Urol (2007) 1.60
Assembly, specific binding, and crystallization of a human TCR-alphabeta with an antigenic Tax peptide from human T lymphotropic virus type 1 and the class I MHC molecule HLA-A2. J Immunol (1996) 1.59
Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models. Proc Natl Acad Sci U S A (2001) 1.58
Detection of squirrel monkey retroviral sequences in interferon samples. J Hepatol (1998) 1.57
An activated rasN gene: detected in late but not early passage human PA1 teratocarcinoma cells. Science (1984) 1.56
Cells transformed by certain strains of Moloney sarcoma virus contain murine p60. Cell (1977) 1.56
Determination of v-Mos-catalyzed phosphorylation sites and autophosphorylation sites on MAP kinase kinase by ESI/MS. Biochemistry (1995) 1.52
Down-regulation of MET, the receptor for hepatocyte growth factor. Oncogene (2001) 1.52
Malignant paraganglioma of the urinary bladder. A case report. Int Urol Nephrol (2001) 1.51
Met expression and sarcoma tumorigenicity. Cancer Res (1993) 1.50
Efficacy and outcome of surgical intervention in patients with nephrolithiasis and chronic renal failure. Int Urol Nephrol (2001) 1.49
The ERGB/Fli-1 gene: isolation and characterization of a new member of the family of human ETS transcription factors. Cell Growth Differ (1992) 1.49
Symptoms of autonomic dysfunction in chronic fatigue syndrome. QJM (2007) 1.45
Perioperative outcome of initial 190 cases of robot-assisted laparoscopic radical prostatectomy - A single-center experience. Indian J Urol (2012) 1.45
Physical map of the origin of defective DNA in herpes simplex virus type 1 DNA. J Virol (1978) 1.44
Can academic radiology departments become more efficient and cost less? Radiology (1998) 1.40
Positive feedback between MAP kinase and Mos during Xenopus oocyte maturation. Dev Biol (1996) 1.39
Ets transcription factors and targets in osteogenesis. Oncogene (2000) 1.39
Persistent herpes simplex virus infections established in two Burkitt lymphoma derived cell lines. J Gen Virol (1976) 1.38
A p60 polypeptide in the feline leukemia virus pseudotype of Moloney sarcoma virus with murine leukemia virus p30 antigenic determinants. Proc Natl Acad Sci U S A (1975) 1.37
Long terminal repeat enhancement of v-mos transforming activity: identification of essential regions. J Virol (1983) 1.36
Ability of the c-mos product to associate with and phosphorylate tubulin. Science (1991) 1.35
Analysis of the early embryonic cell cycles of Xenopus; regulation of cell cycle length by Xe-wee1 and Mos. Development (1998) 1.33
A novel epithelial-expressed ETS gene, ELF3: human and murine cDNA sequences, murine genomic organization, human mapping to 1q32.2 and expression in tissues and cancer. Oncogene (1997) 1.33
Characterization and localization of the products of the human homologs of the v-ets oncogene. Oncogene (1988) 1.31
Mouse Mos protooncogene product is present and functions during oogenesis. Proc Natl Acad Sci U S A (1989) 1.30
Autocrine hepatocyte growth factor/scatter factor-Met signaling induces transformation and the invasive/metastastic phenotype in C127 cells. Oncogene (1996) 1.30
Isolation of the structural polypeptides of foot-and-mouth disease virus and analysis of their C-terminal sequences. Virology (1973) 1.30
Mouse c-mos oncogene activation is prevented by upstream sequences. Proc Natl Acad Sci U S A (1984) 1.30
A mitochondrial membrane protein defined by a novel monoclonal antibody is preferentially detected in apoptotic cells. J Immunol (1996) 1.29
Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathways. Proc Natl Acad Sci U S A (2001) 1.28
ETS2 overexpression in transgenic models and in Down syndrome predisposes to apoptosis via the p53 pathway. Hum Mol Genet (2003) 1.28